Skip to main content
Clinical Trials/NCT01860573
NCT01860573
Completed
N/A

Neurodevelopmental and Growth Outcomes of Early, Aggressive Protein Intake in Very Low Birthweight Infants

Women and Infants Hospital of Rhode Island1 site in 1 country168 target enrollmentNovember 2008
ConditionsPrematurity
InterventionsAmino acids

Overview

Phase
N/A
Intervention
Amino acids
Conditions
Prematurity
Sponsor
Women and Infants Hospital of Rhode Island
Enrollment
168
Locations
1
Primary Endpoint
Number of Participants With Weight<10th Percentile for Age
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

The purpose of this study is to determine whether providing increased protein to premature infants in the first week of life allows for better growth during the hospital stay and improved developmental outcomes by age 2.

Registry
clinicaltrials.gov
Start Date
November 2008
End Date
December 2016
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Women and Infants Hospital of Rhode Island
Responsible Party
Principal Investigator
Principal Investigator

Joseph Bliss

Staff Neonatologist

Women and Infants Hospital of Rhode Island

Eligibility Criteria

Inclusion Criteria

  • birth weight 400 to 1250 grams
  • 24 0/7 to 30 6/7 weeks gestational age

Exclusion Criteria

  • chromosomal, structural, metabolic, endocrine, or renal abnormalities that could affect growth
  • infants \>18 hours of age
  • infants in extremis who are unlikely to survive past 72 hours

Arms & Interventions

Standard amino acids

Receive 1-2 gm/kg/day amino acids at birth and advanced by 0.5 gm/kg/day for goal of 4 gm/kg/day

Intervention: Amino acids

High amino acids

Receive 3-4 gm/kg/day amino acids at birth and advanced to goal of 4 gm/kg/day as soon as possible after birth

Intervention: Amino acids

Outcomes

Primary Outcomes

Number of Participants With Weight<10th Percentile for Age

Time Frame: 36 weeks post-conceptual age

Number of Participants With Length <10th Percentile for Age

Time Frame: 36 weeks post-conceptual age

Number of Participants With Head Circumference <10th Percentile for Age

Time Frame: 36 weeks post-conceptual age

Cognitive Development Score

Time Frame: 18-22 months corrected gestational age

Reported as units on a scale with mean of 100 and a Standard Deviation of 15, and range from 40-160. Higher values indicate a better outcome.

Secondary Outcomes

  • Serum Creatinine(Day of life 1, 2, 3, 5 and 7)
  • Serum Blood Urea Nitrogen(Day of life 1, 2, 3, 5 and 7)
  • Serum Bicarbonate(Day of life 1, 2, 3, 5 and 7)

Study Sites (1)

Loading locations...

Similar Trials